Clinical Innovation in Acute Myeloid Leukemia (AML)

Clinical Innovation in Acute Myeloid Leukemia (AML) is organized by ReachMD.

Course Release Date: 09/30/2022
Expiration Date: 09/30/2023

Overview:
Developments over the last few years have brought dramatic changes to the treatment landscape of acute myeloid leukemia (AML). While new therapies mean more opportunities to individualize care, clinicians are also faced with new challenges and must quickly evaluate patients, order appropriate molecular tests, assess risk, and differentiate the efficacy, safety, and applicability of novel treatments and combinations. Join Drs. Courtney DiNardo and Marina Konopleva for a discussion of how to untangle the data to determine which treatment is right for each patient in the increasingly complex clinical setting of AML.

Learning Objectives:
After participating in this educational activity, participants should be better able to:
• Recognize appropriate molecular tests for patients with acute myeloid leukemia (AML)
• Discuss risk stratification models for patients with AML
• Summarize clinical trial data surrounding new therapies for patients with AML
• Select therapies for patients with AML based on individualized factors